Market Cap 3.80B
Revenue (ttm) 0.00
Net Income (ttm) -144.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 885,500
Avg Vol 2,659,824
Day's Range N/A - N/A
Shares Out 111.42M
Stochastic %K 19%
Beta -0.13
Analysts Strong Sell
Price Target $40.82

Company Profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of so...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 682 0917
Website: amylyx.com
Address:
55 Cambridge Parkway, Suite 6W, Cambridge, United States
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:46 PM
$RXRX AI in Biology 🚀 Bio 💎 s $AMLX $75 $SMMT $40 $SANA $10 plus 🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:35 PM
$RXRX Good Morning ☕️ $SANA $AMLX $PRME
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 4:45 PM
$AMLX Alright JPM upgrades 1.1 TRILLION biotech $LLY because of diversified pipeline. 20 Billion to get AMLX is great value! $100-$120 buyout🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 2:20 PM
$AMLX 🤔 I am thinking what Phase 2 asset this company can buy in the Endo space with that 800 Million war chest. Yeah they could themselves bought out. Exciting times. Let the bidding wars begin☕️ $LLY $NVO
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 1:33 PM
$AMLX Good Morning my Bio 💎s ☕️$SMMT $RXRX $SANA
0 · Reply
Merlintrader
Merlintrader Sep. 2 at 1:16 AM
Amylyx Pharmaceuticals ($AMLX) Stock Hub 2026: LUCIDITY Hit Its Endpoint and a 500M Offering Followed — What Does the NDA Need Now? Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/amylyx-pharmaceuticals-stock-hub/
0 · Reply
SilentBull69
SilentBull69 Sep. 1 at 4:23 PM
$NCLH $AMLX $CCL $JBLU Well, these algorithms & hedge funds have taken full advantage of Middle East news which has squat to do with these companies since 70% of that oil over there now travel through Overland pipelines …not to mention Iran is being starved out financially because of Scott Bessent’s help within the Trump admin💥 But as usual, the left-wing media just focuses on negative news as they try to keep their boot on the news outlets, …and that it’s not nearly as relevant as they make it out to be🎯 And I’m also surprised that the left-wing media completely ignores this 86 billion barrel oil deal that Trump just made with Venezuela where we get 55% of that captured oil and it’s crude just like our refineries in the US are used to dealing with It’s like every time we get solid news they just trap it down with some other negative news and these MM’s and hedge funds run their algorithms to pick up all that spoofing noise to drive everybody down using their illegal tactics✌️
1 · Reply
LibertarianTreehugger
LibertarianTreehugger Sep. 1 at 3:22 PM
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%? https://www.fool.com/investing/2026/09/01/is-glp-1-stock-amylyx-still-buy-after-skyrocketing/ $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 1 at 2:35 PM
$AMLX Good Morning my bio 💎 s☕️ $SMMT $RXRX $SMMT
0 · Reply
mktrdr59
mktrdr59 Aug. 31 at 11:35 PM
$AMLX making a three wave measured move pullback to the .382 retracement level on declining volume. Possible significant wave 5 higher to come.
0 · Reply
Latest News on AMLX
Amylyx price target raised to $57 from $55 at Guggenheim

2026-08-27T11:06:36.000Z - 9 days ago

Amylyx price target raised to $57 from $55 at Guggenheim


Amylyx price target raised to $42 from $30 at Mizuho

2026-08-19T11:26:04.000Z - 17 days ago

Amylyx price target raised to $42 from $30 at Mizuho


Amylyx price target raised to $55 from $40 at Guggenheim

2026-08-19T11:25:30.000Z - 17 days ago

Amylyx price target raised to $55 from $40 at Guggenheim


Amylyx price target raised to $52 from $28 at Baird

2026-08-19T10:55:12.000Z - 17 days ago

Amylyx price target raised to $52 from $28 at Baird


Amylyx price target raised to $39 from $30 at BofA

2026-08-19T09:45:08.000Z - 17 days ago

Amylyx price target raised to $39 from $30 at BofA


Amylyx announces $350M common stock offering

2026-08-18T20:05:24.000Z - 18 days ago

Amylyx announces $350M common stock offering


Amylyx price target raised to $52 from $28 at Baird

2026-08-18T19:05:08.000Z - 18 days ago

Amylyx price target raised to $52 from $28 at Baird


Amylyx price target raised to $55 from $34 at H.C. Wainwright

2026-08-18T16:20:09.000Z - 18 days ago

Amylyx price target raised to $55 from $34 at H.C. Wainwright


Amylyx rises 49.1%

2026-08-18T16:05:36.000Z - 18 days ago

Amylyx rises 49.1%


Amylyx price target raised to $45 from $21 at Stifel

2026-08-18T15:20:14.000Z - 18 days ago

Amylyx price target raised to $45 from $21 at Stifel


Stifel views Amylyx data as ‘best-case scenario’

2026-08-18T14:10:10.000Z - 18 days ago

Stifel views Amylyx data as ‘best-case scenario’


Amylyx Phase 3 data support FDA approval, says Citi

2026-08-18T14:05:36.000Z - 18 days ago

Amylyx Phase 3 data support FDA approval, says Citi


Amylyx rises 41.7%

2026-08-18T14:00:23.000Z - 18 days ago

Amylyx rises 41.7%


Amylyx Pharmaceuticals Transcript: Study result

Aug 18, 2026, 8:00 AM EDT - 18 days ago

Amylyx Pharmaceuticals Transcript: Study result


Amylyx Pharmaceuticals Press release: Study result

Aug 18, 2026, 8:00 AM EDT - 18 days ago

Amylyx Pharmaceuticals Press release: Study result


Amylyx Pharmaceuticals Slides: Study result

Aug 18, 2026, 8:00 AM EDT - 18 days ago

Amylyx Pharmaceuticals Slides: Study result


Amylyx announces Lucidity Phase 3 trial met primary endpoint

2026-08-18T11:06:53.000Z - 18 days ago

Amylyx announces Lucidity Phase 3 trial met primary endpoint


Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2026


Amylyx Pharmaceuticals Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Amylyx Pharmaceuticals Earnings release: Q2 2026


Amylyx Pharmaceuticals Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Amylyx Pharmaceuticals Quarterly report: Q2 2026


Amylyx Pharmaceuticals Transcript: AGM 2026

Jun 4, 2026, 9:00 AM EDT - 3 months ago

Amylyx Pharmaceuticals Transcript: AGM 2026


Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q1 2026


Amylyx Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Earnings release: Q1 2026


Amylyx Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Quarterly report: Q1 2026


Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing


Amylyx Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Amylyx Pharmaceuticals Proxy statement: Proxy filing


Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q4 2025


Amylyx Pharmaceuticals Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Annual report: Q4 2025


Amylyx Pharmaceuticals Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Earnings release: Q4 2025


Amylyx Pharmaceuticals Slides: Corporate presentation

Mar 2, 2026, 6:00 AM EST - 6 months ago

Amylyx Pharmaceuticals Slides: Corporate presentation


Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q3 2025


Amylyx Pharmaceuticals Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Quarterly report: Q3 2025


Amylyx Pharmaceuticals Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Amylyx Pharmaceuticals Earnings release: Q3 2025


Amylyx Pharmaceuticals Slides: Corporate Presentation

Sep 12, 2025, 7:30 AM EDT - 11 months ago

Amylyx Pharmaceuticals Slides: Corporate Presentation


Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings Call Transcript: Q2 2025


Amylyx Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Quarterly report: Q2 2025


Amylyx Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Amylyx Pharmaceuticals Earnings release: Q2 2025


Amylyx Pharmaceuticals Transcript: Status Update

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Transcript: Status Update


Amylyx Pharmaceuticals Press release: Status Update

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Press release: Status Update


Amylyx Pharmaceuticals Slides: Status Update

Jul 13, 2025, 9:00 PM EDT - 1 year ago

Amylyx Pharmaceuticals Slides: Status Update


LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:46 PM
$RXRX AI in Biology 🚀 Bio 💎 s $AMLX $75 $SMMT $40 $SANA $10 plus 🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 4 at 1:35 PM
$RXRX Good Morning ☕️ $SANA $AMLX $PRME
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 4:45 PM
$AMLX Alright JPM upgrades 1.1 TRILLION biotech $LLY because of diversified pipeline. 20 Billion to get AMLX is great value! $100-$120 buyout🚀
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 2:20 PM
$AMLX 🤔 I am thinking what Phase 2 asset this company can buy in the Endo space with that 800 Million war chest. Yeah they could themselves bought out. Exciting times. Let the bidding wars begin☕️ $LLY $NVO
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 2 at 1:33 PM
$AMLX Good Morning my Bio 💎s ☕️$SMMT $RXRX $SANA
0 · Reply
Merlintrader
Merlintrader Sep. 2 at 1:16 AM
Amylyx Pharmaceuticals ($AMLX) Stock Hub 2026: LUCIDITY Hit Its Endpoint and a 500M Offering Followed — What Does the NDA Need Now? Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/amylyx-pharmaceuticals-stock-hub/
0 · Reply
SilentBull69
SilentBull69 Sep. 1 at 4:23 PM
$NCLH $AMLX $CCL $JBLU Well, these algorithms & hedge funds have taken full advantage of Middle East news which has squat to do with these companies since 70% of that oil over there now travel through Overland pipelines …not to mention Iran is being starved out financially because of Scott Bessent’s help within the Trump admin💥 But as usual, the left-wing media just focuses on negative news as they try to keep their boot on the news outlets, …and that it’s not nearly as relevant as they make it out to be🎯 And I’m also surprised that the left-wing media completely ignores this 86 billion barrel oil deal that Trump just made with Venezuela where we get 55% of that captured oil and it’s crude just like our refineries in the US are used to dealing with It’s like every time we get solid news they just trap it down with some other negative news and these MM’s and hedge funds run their algorithms to pick up all that spoofing noise to drive everybody down using their illegal tactics✌️
1 · Reply
LibertarianTreehugger
LibertarianTreehugger Sep. 1 at 3:22 PM
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%? https://www.fool.com/investing/2026/09/01/is-glp-1-stock-amylyx-still-buy-after-skyrocketing/ $AMLX
0 · Reply
LoveRetailFroth
LoveRetailFroth Sep. 1 at 2:35 PM
$AMLX Good Morning my bio 💎 s☕️ $SMMT $RXRX $SMMT
0 · Reply
mktrdr59
mktrdr59 Aug. 31 at 11:35 PM
$AMLX making a three wave measured move pullback to the .382 retracement level on declining volume. Possible significant wave 5 higher to come.
0 · Reply
SilentBull69
SilentBull69 Aug. 31 at 6:24 PM
$AMLX These market makers are working overtime to try to get all weak hands out of this stock 
0 · Reply
LoveRetailFroth
LoveRetailFroth Aug. 31 at 3:31 PM
$AMLX $LLY Good Morning ☕️ $100 buyout to close the GLP-1 loop & Wolfarm & ASO optionality
0 · Reply
healthcareguru
healthcareguru Aug. 31 at 3:20 PM
$AMLX i watned you…crashed through deal price and on hot route to $30…night night. 🤦‍♂️👎 $XBI $XLV
0 · Reply
Daedal
Daedal Aug. 31 at 12:10 PM
$AMLX More reasons for this to be acquired sooner rather than later?
0 · Reply
ajmore
ajmore Aug. 31 at 7:06 AM
$AMLX "should Eli Lilly $LLY investors be worried about a threat from Amylyx" The Motely Fool RSS we are defo in this space, with 4-6bln projected sales of avexitide and a lot of cash (800mln + ). Maybe its Eli Lilly the one to swoop in!
1 · Reply
LongBull67
LongBull67 Aug. 30 at 7:15 PM
$AMLX so what is the instance of hypoglycemia when taking a glp1? It seems this scenario would be easily corrected by eating, not adding another medication. According to chat gpt instances of hypoglycemia with glp1 monotherapy is very rare. There is a greater risk for hypoglycemia when a diabetic takes insulin but glp1 meds are warned off when a person takes insulin. The chance of hypoglycemia with metformin is low because it has a different mechanism of action to glp1 meds. I’m holding puts thinking this will retrace at least back to 30 in the short term
4 · Reply
ajmore
ajmore Aug. 29 at 9:32 AM
$AMLX people 👇 dont understand what is an 1. orphan drug 2. only drug 3. complementary to glp1 s 4. 2 other drugs in pipeline. here's my prediction: company has been approached by suitors. 80-100 on the cards.
0 · Reply
Bobos38
Bobos38 Aug. 28 at 9:43 PM
0 · Reply
Crowsupervision
Crowsupervision Aug. 28 at 8:09 PM
$ARCT Done with $AMLX Kicked that garbage to the curb and moved into $ARCT.
2 · Reply
SilentBull69
SilentBull69 Aug. 28 at 7:59 PM
$AMLX 💥💥UNMASKING THE BLATANT LATE-FRIDAY MANUFACTURED TAKEDOWN ON AMLX 💥💥 Retail is falling for standard pre-weekend tute stop-hunting Look at the tape and read the mechanical data **OVERSOLD….The 30-minute RSI is slammed into the dirt near 20 an asset cannot remain this artificially oversold unless algorithms are pulling bid support to force trailing stops to explode **Last week’s upsized $500M public offering at a hard $35.50 price is already cleared and locked into AMLX’s war chest. This sub-$35 drift is completely artificial paper-shuffling, NOT fundamental failures💥 **MM’s are intentionally dragging the price to its absolute low today They want retail flippers to panic about holding over the weekend so tute dark pools can swoop up / accumulate these cheap shares Their fundamentals are flawless, the cash war chest is topped off to fund the global commercial launch for avexitide, and the FDA NDA submission remains firmly on track for the tail end of 2026✌️
0 · Reply
SilentBull69
SilentBull69 Aug. 28 at 7:38 PM
$AMLX As you can see all of this is hedge fund tricky and the nonsense they pull with their algorithms. This is 100% them screwing with the stock price to flush out options so they can keep the premiums. Look at all the 100 share blocks …that’s pure algorithm spoofing  Know what you own ✌️
0 · Reply
ajmore
ajmore Aug. 28 at 6:42 PM
$AMLX sold with all small and mid cap stocks today on fed member talk. the thing is ORPHAN DRUGS PHARMA are not influenced by these. opportunity to increase position or open one in case you dont hold.
1 · Reply